Bcr-Abl inhibition as a modality of CML therapeutics.

Source:http://linkedlifedata.com/resource/pubmed/id/11553417

Biochim. Biophys. Acta 2001 Aug 31 1551 1 M11-8

Download in:

View as

Triples

General Info

PMID
11553417